Literature DB >> 23697749

An excess of prior irritable bowel syndrome diagnoses or treatments in Celiac disease: evidence of diagnostic delay.

Timothy R Card1, Jesse Siffledeen, Joe West, Kate M Fleming.   

Abstract

OBJECTIVE: It is recognized that celiac disease can present with symptoms characteristic of irritable bowel syndrome (IBS) and that a substantial proportion of patients referred to gastroenterologists with these symptoms may have celiac disease. The authors set out to discover how commonly those suffering with celiac disease are misdiagnosed as suffering from IBS and whether such misdiagnosis delays the correct diagnosis.
MATERIALS AND METHODS: A case control study using computerized records from the General Practice Research Database was conducted. The authors compared the proportion of patients with celiac disease who had a diagnosis of or had undergone treatment for IBS over a variety of time periods before the diagnosis of celiac disease with the proportion of a matched group without celiac disease who were similarly diagnosed or treated.
RESULTS: It was found that 16% of celiac patients had such a prior diagnosis compared to 4.9% of controls (a threefold increased risk of prior IBS; OR = 3.8, 95% CI: 3.6-4.2), and that if one looked at typical treatment for IBS rather than diagnostic codes, 28% of celiac patients appeared to have been treated compared to 9% of controls. Many of the diagnoses of IBS occurred within the last year before diagnosis of celiac disease, but there was a clear excess of IBS even 10 years earlier.
CONCLUSIONS: In contemporary UK practice, it is likely that at least some patients with celiac disease spend many years being treated as having IBS. Following guidelines to test serologically for celiac disease will minimize this problem.

Entities:  

Mesh:

Year:  2013        PMID: 23697749     DOI: 10.3109/00365521.2013.786130

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

1.  Delayed celiac disease diagnosis predisposes to reduced quality of life and incremental use of health care services and medicines: A prospective nationwide study.

Authors:  Valma Fuchs; Kalle Kurppa; Heini Huhtala; Markku Mäki; Leila Kekkonen; Katri Kaukinen
Journal:  United European Gastroenterol J       Date:  2018-01-08       Impact factor: 4.623

2.  Characteristics and factors related to quality of life in Mexican Mestizo patients with celiac disease.

Authors:  Karen Lizzete Ramírez-Cervantes; José María Remes-Troche; María Del Pilar Milke-García; Viridiana Romero; Luis F Uscanga
Journal:  BMC Gastroenterol       Date:  2015-01-22       Impact factor: 3.067

Review 3.  New insights in IBS-like disorders: Pandora's box has been opened; a review.

Authors:  Raffaele Borghini; Giuseppe Donato; Domenico Alvaro; Antonio Picarelli
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

Review 4.  Mechanism-Oriented Therapy of Irritable Bowel Syndrome.

Authors:  Juan R Malagelada; Carolina Malagelada
Journal:  Adv Ther       Date:  2016-04-30       Impact factor: 3.845

5.  Early recognition of coeliac disease through community pharmacies: a proof of concept study.

Authors:  Heidi Urwin; David Wright; Michael Twigg; Norma McGough
Journal:  Int J Clin Pharm       Date:  2016-08-08

Review 6.  Pitfalls in the Diagnosis of Coeliac Disease and Gluten-Related Disorders.

Authors:  Annalisa Schiepatti; Jessica Savioli; Marta Vernero; Federica Borrelli de Andreis; Luca Perfetti; Antonio Meriggi; Federico Biagi
Journal:  Nutrients       Date:  2020-06-07       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.